Supplementary materials: Identification of a lncRNA Prognostic Signature-related to Stem Cells index and its Significance in Colorectal Cancer

<b>Figure S1: X-tile plots of
mRNAsi-related lncRNA signature for optimal cut-off determination in the
training cohort. </b>(A-B) The cut-off
(IRS= 0.97) was optimized to separate low mRNAsi-related lncRNA signature
(blue) from high mRNAsi-related lncRNA signature (gray) in the frequency
histogram of the training cohort. (C) Kaplan-Meier curve for testing the
survival of sample subsets defined by the optimized cutoff value of
mRNAsi-related lncRNA signature.<b></b>
<b> </b>
<b>Table
S1. </b>List
of TCGA IDs for randomly grouped training and validation cohort<b></b>
<b> </b>
<b>Table
S2. </b>The
univariate screening of mRNAsi-related lncRNA for overall survival in the
training

<b>Table
S3. </b>The
univariate screening of mRNAsi-related lncRNA for overall survival in the
training cohort

<b>Table
S4.</b> The
univariate analysis of mRNAsi-related lncRNA signature for overall survival
in the training cohort
<b> </b>
<b>Table
S5.</b> The
univariate analysis of mRNAsi-related lncRNA signature for overall survival
in the validation cohort

<b>Table
S6. </b>The
correlation of each of five mRNAsi-related lncRNAs with mRNA from the same patients

<b>Table
S7. </b>The
GO analysis of the mRNAsi-related lncRNA signature

<b>Table
S8. </b>The
KEGG pathway analysis of the mRNAsi-related lncRNA signature